dailypolitical.com
Positivewww.dailypolitical.com ·
usana health sciences nyseusna issues earnings results
GENERAL_HEALTHMEDICALECON_STOCKMARKETTAX_ECON_PRICE
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedUSANA Health Sciences, a direct seller of nutritional supplements, beat earnings and revenue estimates, raising FY2026 guidance. The beat reflects stronger demand or operational efficiency, but the insider sale tempers enthusiasm. The impact is company-specific, with no broad sector or supply chain implications. Commercial mechanism is weak: earnings beat may improve margins short-term, but no input cost or scarcity channel is evident.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- USANA reported Q1 2026 EPS of $0.61 vs estimate $0.44, revenue $250.22M vs $240.99M.
- Fiscal 2026 EPS guidance raised to $1.95-$2.29 per share.
- Stock rose 3.4% to $19.19 after earnings.
- Insider Joshua Foukas sold 4,461 shares at $21.34.
- Institutional ownership at 54.25%.